Myeloproliferative Neoplasm | MPN | driver mutations of CML, CNL, CEL | Dr. Tejindar Singh, Oncquest
Oncquest has organized 18th webinar on 8th October'2020. This is the video recording of live session which will provide you the detail information about Myeloproliferative Neoplasm (MPN) and Driver Mutation of CML, CNL, CEL. The speaker of the webinar is Dr Tejinder Singh and moderator is Dr Priya Murthy.
Myeloproliferative Neoplasms (MPNs) are a group of blood cancers in which excess red blood cells, white blood cells or platelets are produced in the bone marrow. Myeloproliferative Neoplasm (MPN) refers to the bone marrow, proliferative describes the rapid growth of blood cells and neoplasm describes that growth as abnormal and uncontrolled.
About Oncquest Laboratories Ltd.
Oncquest Laboratories is a leader in Oncology testing with a legacy spanning 2 decades. It has been a forerunner in the molecular diagnostics services across India and neighboring countries.
A favourite amongst clinicians, specialty hospitals, and other path labs, Oncquest is known for second opinion and final diagnosis, using most advanced technology and skills.
Oncquest national footprint spans 43 Labs, 350 Collection Centers & 1700+ Service Associates. It conducts over 4,000 different tests - from the routine to the most complex, spanning over 200 technologies.
Oncquest has a highly skilled and globally reputed team of qualified doctors with combined experience of 600+ years. Its logistic capabilities and Pan Asia geographical spread makes Oncquest an ideal associate for all clinical activities.
Oncquest is promoted by the Burman family - the promoters of Dabur.
For any queries related to test,
Mails us: life@oncquest.net
Website: https://www.oncquest.net/
Facebook: https://www.facebook.com/OncquestLaboratories/
LinkedIn: https://www.linkedin.com/compa....ny/oncquest-labs-ltd
Contact Us : 7065350350/ 01130611432/ 467
-
Category
No comments found